Does Rallies show Form 4 insider transactions for MEDP?

Yes. Rallies tracks MEDP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MEDP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MEDP. It does not provide personalized investment advice.

MEDP (Medpace Holdings, Inc. Common Stock) Stock Analysis - Insider Trades

Medpace Holdings, Inc. Common Stock (MEDP) is a publicly traded Healthcare sector company. As of May 20, 2026, MEDP trades at $422.00 with a market cap of $12.01B and a P/E ratio of 25.82. MEDP moved +0.51% today. Year to date, MEDP is -28.11%; over the trailing twelve months it is +37.59%. Its 52-week range spans $250.05 to $628.92. Analyst consensus is buy with an average price target of $447.50. Rallies surfaces MEDP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MEDP stock inside the company?

Recent MEDP insider activity includes GEIGER JESSE J sold 31.71K, Troendle August J. sold 668, Troendle August J. sold 5.70K, Troendle August J. sold 23.18K, and Troendle August J. sold 15.15K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MEDP Key Metrics

Key financial metrics for MEDP
Metric	Value
Price	$422.00
Market Cap	$12.01B
P/E Ratio	25.82
EPS	$16.22
Dividend Yield	0.00%
52-Week High	$628.92
52-Week Low	$250.05
Volume	333.70K
Avg Volume	0
Revenue (TTM)	$2.68B
Net Income	$460.40M
Gross Margin	29.07%

Recent MEDP Insider Trades

GEIGER JESSE J sold 31.71K (~$14.44M) on Mar 17, 2026.
Troendle August J. sold 668 (~$394.58K) on Dec 3, 2025.
Troendle August J. sold 5.70K (~$3.36M) on Dec 2, 2025.
Troendle August J. sold 23.18K (~$13.75M) on Dec 1, 2025.
Troendle August J. sold 15.15K (~$8.99M) on Nov 28, 2025.

Latest MEDP News

Medpace climbs as Q1 beat and FY2026 outlook keep buyers active — May 5, 2026
Medpace jumps 4% as traders buy dip after cancellation-driven earnings selloff — Apr 26, 2026
Medpace rebounds after steep post-earnings selloff as investors refocus on Q1 beat — Apr 25, 2026
Medpace rebounds 3% as investors reassess Q1 beat after bookings-driven selloff — Apr 24, 2026
Medpace Q1 Revenue Jumps 26.5% to $706.6M, EBITDA Up 25.9% — Apr 24, 2026

MEDP Analyst Consensus

8 analysts cover MEDP: 0 strong buy, 3 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $447.50.

Common questions about MEDP

Who is trading MEDP stock inside the company?: Recent MEDP insider activity includes GEIGER JESSE J sold 31.71K, Troendle August J. sold 668, Troendle August J. sold 5.70K, Troendle August J. sold 23.18K, and Troendle August J. sold 15.15K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MEDP?: Yes. Rallies tracks MEDP insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MEDP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MEDP. It does not provide personalized investment advice.